Skip to main content
. 2022 Mar 1;12:842418. doi: 10.3389/fonc.2022.842418

Figure 1.

Figure 1

GRP78 expression and outcome in HNSCC patients. (A, B) DEA shows increased GRP78 gene expression in HNSCC tumor tissue (n = 500) in comparison to the non-cancerous tissue samples (n = 44). Data was retrieved from the TCGA database. (B) Comparison of GRP78 expression in paired tumor and non-cancerous tissue samples (n = 43 for both). (C) Kaplan-Meier (KM) survival analysis of HNSCC patients showing decreased survival associated with high GRP78 expression. Survival analysis was evaluated with log-rank test (p = 0.0165).